Teri Carlson
Psychiatry · Boulder, CONPI 1912910605
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 541 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 541 payments — averaging $17.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Tris Pharma Inc$1K
- Supernus Pharmaceuticals, Inc.$734
- Ironshore Pharmaceuticals Inc.$707
- Corium, LLC$686
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$533
- plus $4K from 19 others
What the payments were for
- Food & beverage$9,558100%
- Education$390%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 88 | $1,535 |
| Tris Pharma Inc | 52 | $1,364 |
| Supernus Pharmaceuticals, Inc. | 35 | $734 |
| Ironshore Pharmaceuticals Inc. | 56 | $707 |
| Corium, LLC | 38 | $686 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 36 | $533 |
| Otsuka America Pharmaceutical, Inc. | 28 | $456 |
| Vanda Pharmaceuticals Inc. | 23 | $449 |
| Lundbeck LLC | 21 | $429 |
| Sunovion Pharmaceuticals Inc. | 28 | $328 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $311 |
| Alkermes, Inc. | 14 | $268 |
| Idorsia Pharmaceuticals US Inc | 17 | $229 |
| Adlon Therapeutics L.p. | 14 | $213 |
| Noven Therapeutics, LLC | 11 | $200 |
| Johnson & Johnson | 9 | $181 |
| Collegium Pharmaceutical, Inc. | 9 | $177 |
| Bausch Health US, LLC | 8 | $174 |
| Teva Pharmaceuticals USA, Inc. | 9 | $165 |
| Axsome Therapeutics, Inc. | 6 | $138 |
| Vertical Pharmaceuticals, LLC | 5 | $96 |
| E.r. Squibb & Sons, L.L.C. | 3 | $66 |
| Tempus AI, Inc | 3 | $61 |
| Neurocrine Biosciences, Inc. | 3 | $51 |
| Brainsway USA Inc | 2 | $46 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$154
- Dyanavel XR$109
How this compares
$9,598 in reported general payments places this provider in the 95th percentile of 559 psychiatry providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 18 | $821 |
| Quetiapine Fumarate | 25 | $756 |
| Lamotrigine | 46 | $630 |
| Trazodone Hcl | 26 | $467 |
| Escitalopram Oxalate | 31 | $441 |
| Gabapentin | 25 | $273 |
| Lorazepam | 16 | $228 |
| Eszopiclone | 13 | $55 |
| Hydroxyzine Hcl | 12 | $53 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Boulder
- David RosenthalBoulder$10K
- Gerald ChittersBoulder$3K
- John HardyPueblo$828K
- Larry SandersLittleton$760K
- Jeffrey RichmondDenver$424K
- Jennifer FrenchGlendale$115K
- Charles ParkLone Tree$89K
- Cynthia EppersonAurora$64K
- Brian WiseCentennial$44K
- Robert CowanCentennial$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.